Aakaar Medical Technologies Ltd (AAKAAR) is currently trading at 50.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Aakaar Medical Technologies Ltd. specializes in manufacturing and distributing medical aesthetic products and devices, targeting dermatologists, plastic surgeons, and other aesthetic practitioners. The company launched its IPO in June 2025, raising INR 27 crores, which it is using to strengthen its working capital and expand its reach within the medical aesthetic industry. Despite an 8.6% decline in revenue in H1FY26, the company is experiencing strong customer growth, adding 900+ new clients and expanding its product offerings to 154 SKUs. Aakaar has formed strategic partnerships with international companies to distribute premium-quality aesthetic solutions in India, ensuring access to advanced products for its clients. The introduction of new divisions, such as the high-margin EXOVEA range, signifies Aakaar's ambition to lead the evolution of India's aesthetic market through innovation and market expansion.

Over the past 52 weeks, Aakaar Medical Technologies Ltd has traded between a low of ₹46.00 and a high of ₹98.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Aakaar Medical Technologies Ltd has a market capitalization of approximately 75.61. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Aakaar Medical Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.39 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 75.61 Cr, Aakaar Medical Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Aakaar Medical Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Aakaar Medical Technologies Ltd is 11.39. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.